NCT05204875

Brief Summary

Bronchoscopic lung volume reduction (BLVR) using endobronchial valves is effective in improving quality of life in patients suffering from emphysema. BLVR treatment in advanced emphysema requires targeted segmental or sub-segmental placement of endobronchial valves (EBV) to achieve total lobar occlusion to induce effective lobar volume reduction. BLVR procedure success rate declines in patients with incomplete lobar fissure integrity due to the potential for collateral ventilation to circumvent EBV lobar occlusion. Current methods that assess lobar collateral ventilation as a correlate of fissure integrity are imperfect, resulting in a significant percentage of patients having equivocal assessment, leading to suboptimal selection of patients and potential for inappropriate selection of patients for BLVR. Additionally, methods used to select the target lobe for EBV placement predominately rely on the extent of emphysematous destruction. There is also a need to select based on the extent of physiological disturbance at the lobar level. Distribution of ventilation or regional ventilation heterogeneity may be associated with collateral ventilation. Therefore, in this study we wish to quantify lobar distribution of ventilation and ventilation heterogeneity in patients undergoing investigation for BLVR to determine the additive contribution of functional lung imaging for assessing lobar physiological derangement and suitability for EBV treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

July 5, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

October 24, 2022

Status Verified

October 1, 2022

Enrollment Period

1.3 years

First QC Date

December 22, 2021

Last Update Submit

October 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The objective of the current investigation is to determine whether XV technology can assist in determining lobar selection, indicators of success, or response-related clinical outcomes with BLVR.

    Functional lung imaging analysis in endobronchial valve placement

    functional lung imaging and software analysis will be available after the procedure

Study Arms (1)

Functional lung imaging

Assess the applicability of XV ventilation distribution and heterogeneity for BLVR candidate screening compared to conventional tools of quantitative HRCT and ventilation perfusion scanning.

Radiation: X-ray Velocimetry

Interventions

X-ray Velocimetry (XV) technology images the motion of the lungs, determines airway volumes and measures regional lung ventilation during spontaneous breathing.

Functional lung imaging

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with COPD undergoing bronchoscopic lung volume reduction

You may qualify if:

  • Emphysema
  • Undergoing evaluation and planned treatment with BLVR
  • Adults, 40 years of age and older
  • Consents to functional lung imaging evaluation
  • Access to previous chest CT as part of the clinical workup for BLVR

You may not qualify if:

  • Known contraindication to BLVR
  • Currently receiving mechanical ventilation, intensive or other critical care
  • Pregnant women
  • Contraindication to ionizing radiation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Temple University Hospital

Philadelphia, Pennsylvania, 19140, United States

RECRUITING

MeSH Terms

Conditions

Emphysema

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gerard Criner, MD

    Temple University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Jacobs, PharmD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2021

First Posted

January 24, 2022

Study Start

July 5, 2022

Primary Completion

November 1, 2023

Study Completion

December 1, 2023

Last Updated

October 24, 2022

Record last verified: 2022-10

Locations